Heparin, Low-Molecular-Weight
Concept
Vocabulary Service
Overview
subject area of
-
2 Mechanisms of action of low molecular weight heparins and heparinoids Academic Article
-
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Academic Article
-
4 Clinical potential of low molecular weight heparins Academic Article
-
A Comparison of General Anesthesia and Regional Anesthesia as a Risk Factor for Deep Vein Thrombosis Following Hip Surgery: A Critical Review Academic Article
-
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation Academic Article
-
A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats Academic Article
-
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism Academic Article
-
A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients Academic Article
-
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
-
A review of the two major regulatory pathways for non-proprietary low-molecular-weight heparins Academic Article
-
A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism Academic Article
-
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies Academic Article
-
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery - TREK: a dose-ranging study Academic Article
-
Addressing the burden of hospital-related venous thromboembolism: the role of extended anticoagulant prophylaxis Academic Article
-
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Academic Article
-
Advances and contemporary issues in prophylaxis for deep vein thrombosis. Academic Article
-
Advances in the management of venous thromboembolism. Academic Article
-
Airways Disease Presenting as Restrictive Impairment: Response Academic Article
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy Academic Article
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients Academic Article
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy Academic Article
-
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer Academic Article
-
An Approach to Assigning In Vitro Potency to Unfractionated and Low Molecular Weight Heparins Based on the Inhibition of Prothrombin Activation and Catalysis of Thrombin Inhibition Academic Article
-
An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial Academic Article
-
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial Academic Article
-
An overview of clinical trials of low molecular weight heparin fractions. Academic Article
-
Angina (unstable). Academic Article
-
Angina (unstable). Academic Article
-
Angina (unstable). Academic Article
-
Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery Academic Article
-
Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849) Academic Article
-
Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography Academic Article
-
Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency Academic Article
-
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis Academic Article
-
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis Academic Article
-
Anticoagulant therapy in acute brain ischaemia Academic Article
-
Anticoagulants in acute coronary syndromes Academic Article
-
Anticoagulants in cancer Academic Article
-
Anticoagulation Therapy Academic Article
-
Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group Academic Article
-
Anticoagulation for patients with cancer and central venous catheters Academic Article
-
Anticoagulation for people with cancer and central venous catheters Academic Article
-
Anticoagulation for people with cancer and central venous catheters Academic Article
-
Anticoagulation for people with cancer and central venous catheters Academic Article
-
Anticoagulation for perioperative thromboprophylaxis in people with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters Academic Article
-
Anticoagulation therapy in patients with prosthetic heart valves. Academic Article
-
Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin Academic Article
-
Antithrombins: Their Potential as Antithrombotic Agents Academic Article
-
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Antithrombotic Therapy in Children* Academic Article
-
Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin Academic Article
-
Antithrombotic Therapy in Neonates and Children Academic Article
-
Antithrombotic Therapy in Neonates and Children Academic Article
-
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
-
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents Academic Article
-
Antithrombotic therapy in children with venous thromboembolism Academic Article
-
Antithrombotic therapy: the expanding role of low molecular weight heparin. Academic Article
-
Antithrombotics and Anticoagulants in Coronary Syndromes and Stroke Academic Article
-
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery Academic Article
-
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement Academic Article
-
Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin? Academic Article
-
Aspirin Versus Low-Molecular-Weight Heparin for Ischemic Stroke in Children: An Unanswered Question Academic Article
-
Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin Academic Article
-
Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery Academic Article
-
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey Academic Article
-
Barriers and facilitators to adopting high value practices and de-adopting low value practices in Canadian intensive care units: a multimethod study Academic Article
-
Benefit of Selective Factor Inhibition Academic Article
-
Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials Academic Article
-
Beyond Heparin and Aspirin Academic Article
-
Beyond Unfractionated Heparin and Warfarin Academic Article
-
Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin Academic Article
-
Biologic rationale for the therapeutic role of specific antithrombins Academic Article
-
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures Academic Article
-
Bridging Anticoagulation Academic Article
-
Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
-
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation Academic Article
-
Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery Academic Article
-
Can we differentiate the low-molecular-weight heparins? Academic Article
-
Can we optimise treatment of thrombosis? Academic Article
-
Central venous catheters are an important factor in paediatric thrombosis Academic Article
-
Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management Academic Article
-
Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction Academic Article
-
Changing Paradigms in the Management of Venous Thromboembolism Academic Article
-
Characterization of Heparin Aerosols Generated in Jet and Ultrasonic Nebulizers Academic Article
-
Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism Academic Article
-
Choice of low molecular weight heparins Academic Article
-
Choice of low molecular weight heparins. Academic Article
-
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy Academic Article
-
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry1 Academic Article
-
Clinical potential of antithrombotic drugs in coronary syndromes Academic Article
-
Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies Academic Article
-
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist Academic Article
-
Comparative effects of heparin and LMW heparin on hemostasis Conference Paper
-
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance. Academic Article
-
Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry) Academic Article
-
Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis Conference Paper
-
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism Academic Article
-
Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial Academic Article
-
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism Academic Article
-
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Academic Article
-
Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis. Academic Article
-
Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism Academic Article
-
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Academic Article
-
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines Academic Article
-
Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol Academic Article
-
Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential Academic Article
-
Deep vein thrombosis: update on diagnosis and management Academic Article
-
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis Academic Article
-
Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial Academic Article
-
Diagnosis and Anticoagulant Treatment Academic Article
-
Diagnosis and Treatment of Venous Thromboembolism Academic Article
-
Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation Academic Article
-
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis Academic Article
-
Distal deep vein thrombosis – a benign disease? Academic Article
-
Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin–sodium) in pediatric patients Academic Article
-
Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events Academic Article
-
Dosing Frequency of Unfractionated Heparin Thromboprophylaxis Academic Article
-
ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events. Academic Article
-
Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial Academic Article
-
Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis Academic Article
-
Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review Academic Article
-
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Academic Article
-
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism Academic Article
-
Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate Academic Article
-
Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor Academic Article
-
Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro Academic Article
-
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography Academic Article
-
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation Academic Article
-
Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbits Academic Article
-
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty Academic Article
-
Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients Academic Article
-
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 Academic Article
-
Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis Academic Article
-
Emerging anticoagulants for the treatment of venous thromboembolism Academic Article
-
End of the road for heparin thromboprophylaxis Academic Article
-
Enoxaparin prophylaxis in elective hip surgery. Academic Article
-
Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization. Academic Article
-
Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project Academic Article
-
Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol Academic Article
-
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis Academic Article
-
Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates Academic Article
-
Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis Academic Article
-
Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin Academic Article
-
Exercise-Induced Deep Vein Thrombosis of the Upper Extremity Academic Article
-
Extended Venous Thromboembolism Prophylaxis after Abdominopelvic Cancer Surgery: A Retrospective Review Academic Article
-
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy? Academic Article
-
Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Academic Article
-
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery – the SAVE-HIP3 study Academic Article
-
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism Academic Article
-
Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols Academic Article
-
Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty Academic Article
-
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction Academic Article
-
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE) Academic Article
-
From unfractionated heparins to low molecular weight heparins. Academic Article
-
Glycosaminoglycans Bind Factor Xa in a Ca2+-Dependent Fashion and Modulate Its Catalytic Activity Academic Article
-
Guide to Anticoagulant Therapy: Heparin Academic Article
-
Guide to Anticoagulant Therapy: Heparin Academic Article
-
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association. Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment Academic Article
-
Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients Academic Article
-
Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss Academic Article
-
Heparin and Angiogenesis Academic Article
-
Heparin and Low Molecular Weight Heparins Inhibit Prothrombinase Formation but not its Activity in Plasma Academic Article
-
Heparin and Low-Molecular-Weight Heparin Academic Article
-
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety Academic Article
-
Heparin and Platelets Academic Article
-
Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases Academic Article
-
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
-
Heparin compromises streptokinase-induced arterial patency in rabbits Academic Article
-
Heparin sensitivity and resistance in the neonate: An explanation Academic Article
-
Heparin, Low Molecular Weight Heparin, and Heparin-Induced Thrombocytopenia in the ICU Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia: Real-World Issues Academic Article
-
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention Academic Article
-
Heparin-induced thrombocytopenia and its treatment. Conference Paper
-
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings Academic Article
-
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
-
Heparins in sepsis-induced disseminated intravascular coagulation: Low weight—high impact?* Academic Article
-
High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients Academic Article
-
Hirudin and thrombosis prophylaxis Academic Article
-
Home-treatment of deep vein thrombosis in patients with cancer. Academic Article
-
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy Academic Article
-
How Long to Treat Acute Venous Thrombosis in Cancer: Can Treatment Be Personalized? Academic Article
-
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice Academic Article
-
Impact of the patient population on the risk for heparin-induced thrombocytopenia Academic Article
-
Improving the adoption of optimal venous thromboembolism prophylaxis in critically ill patients: A process evaluation of a complex quality improvement initiative Academic Article
-
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days Academic Article
-
In vitro and ex vivo Activities of CY216: Comparison with Other Low Molecular Weight Heparins Academic Article
-
Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study Conference Paper
-
Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta-analysis of prospective studies Academic Article
-
Induction of the Acute-Phase Reaction Increases Heparin-Binding Proteins in Plasma Academic Article
-
Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin–heparin complex Academic Article
-
Initial treatment of venous thromboembolism Academic Article
-
Interaction of low molecular weight heparin with ketorolac Academic Article
-
International Committee Communications. Standardization and clinical use of LMW heparin. Report of the ICTH Heparin Subcommittee, Brussels, July 1987. Academic Article
-
Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin? Academic Article
-
LMW Heparin for Deep Vein Thrombosis Academic Article
-
Laboratory monitoring of low-molecular-weight heparin therapy Academic Article
-
Limitations of conventional treatment options for heparin-induced thrombocytopenia. Academic Article
-
Localization of heparin and low-molecular-weight heparin in the rat kidney Academic Article
-
Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation? Conference Paper
-
Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy Academic Article
-
Low Molecular Weight Heparin Academic Article
-
Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism Academic Article
-
Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results Academic Article
-
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism Conference Paper
-
Low molecular weight heparin Academic Article
-
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Academic Article
-
Low molecular weight heparin and bleeding in patients with chronic renal failure Academic Article
-
Low molecular weight heparin and unfractionated heparin in the early pharmacologic management of acute coronary syndromes: a meta-analysis of randomized clinical trials. Academic Article
-
Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial Academic Article
-
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
-
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
-
Low molecular weight heparin: a critical analysis of clinical trials. Academic Article
-
Low molecular weight heparin: laboratory properties and clinical evaluation. A review. Academic Article
-
Low molecular weight heparins Academic Article
-
Low molecular weight heparins and heparinoids Academic Article
-
Low molecular weight heparins in the treatment of unstable angina. Academic Article
-
Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke. Academic Article
-
Low-Molecular-Weight Heparin Academic Article
-
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism Academic Article
-
Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months Academic Article
-
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin Academic Article
-
Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction Academic Article
-
Low-Molecular-Weight Heparin for Pulmonary Embolism Academic Article
-
Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results Academic Article
-
Low-Molecular-Weight Heparin in Pediatric Patients Academic Article
-
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism Academic Article
-
Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients Academic Article
-
Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease Academic Article
-
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial Academic Article
-
Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis Academic Article
-
Low-Molecular-Weight Heparins Academic Article
-
Low-Molecular-Weight Heparins and Unstable Angina – Current Perspectives Academic Article
-
Low-Molecular-Weight Heparins in Acute Unstable Coronary Artery Disease – An Update Academic Article
-
Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes Academic Article
-
Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery Academic Article
-
Low-molecular-weight Heparin for the treatment of venous thrombosis in patients with adenocarcinoma Academic Article
-
Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM) Academic Article
-
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants Academic Article
-
Low-molecular-weight heparin for the treatment of venous thromboembolism. Academic Article
-
Low-molecular-weight heparin in patients with chronic renal insufficiency Academic Article
-
Low-molecular-weight heparin in the treatment of pulmonary embolism. Academic Article
-
Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review Academic Article
-
Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial Academic Article
-
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis Academic Article
-
Low-molecular-weight heparin: from the bench to the orthopedic patient. Academic Article
-
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis Academic Article
-
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review Academic Article
-
Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency Academic Article
-
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Academic Article
-
Low‐molecular‐weight heparins and heparinoids Academic Article
-
Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy Academic Article
-
Management Of Venous Thromboembolism: Optimization By Clinical Trials Academic Article
-
Management of Deep Vein Thrombosis and Pulmonary Embolism Academic Article
-
Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B. Academic Article
-
Management of iliofemoral thrombosis in a pregnant patient with heparin resistance Academic Article
-
Management of thromboembolic disease in cancer patients. Academic Article
-
Management of unstable angina and myocardial infarction Academic Article
-
Management of venous thromboembolism in cancer patients. Academic Article
-
Management strategies in unstable coronary artery disease-Current problems and future directions Academic Article
-
Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery Academic Article
-
Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer Academic Article
-
Measuring the anticoagulant effect of low molecular weight heparins in the critically ill. Academic Article
-
Mechanism of Action and Pharmacology of Unfractionated Heparin Academic Article
-
Mechanisms responsible for the failure of protamine
to inactivate low-molecular-weight heparin Academic Article
-
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients Academic Article
-
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux Academic Article
-
Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate? Academic Article
-
Mortality benefits of thromboprophylaxis Academic Article
-
Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate Academic Article
-
New Anticoagulant Strategies Academic Article
-
New Antithrombotic Drugs: Potential for Use in Oncology Academic Article
-
New Frontiers in the Management of Unstable Coronary Artery Disease Academic Article
-
New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins. Academic Article
-
New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin Academic Article
-
Newer Anticoagulants in Critically Ill Patients Academic Article
-
Non-injection-site necrotic skin lesions complicating postoperative heparin thromboprophylaxis Academic Article
-
Nonbleeding complications of unfractionated and low-molecular weight heparins. Academic Article
-
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
-
Novel anticoagulant agents: introduction Academic Article
-
Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis Academic Article
-
Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours Academic Article
-
Overview of low molecular weight heparins and heparinoids: basic and clinical aspects. Academic Article
-
PREVENTION OF VENOUS THROMBO‐EMBOLISM Academic Article
-
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised
pragmatic trial protocol comparing aspirin versus low-molecular-weight
heparin for blood clot prevention in orthopaedic trauma patients Academic Article
-
PRE‐OPERATIVE FACTOR Xa–TFPI AND POST‐OPERATIVE VENOUS THROMBOSIS Academic Article
-
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma Academic Article
-
Parenteral Anticoagulants Academic Article
-
Parenteral Anticoagulants Academic Article
-
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation Academic Article
-
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
-
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
-
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review Academic Article
-
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines Academic Article
-
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
-
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry) Academic Article
-
Perioperative Management of Oral Anticoagulation Academic Article
-
Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question Academic Article
-
Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Academic Article
-
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians Academic Article
-
Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation Academic Article
-
Periprocedural Management of Oral Anticoagulation Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients Conference Paper
-
Pharmacologic tools to reduce bleeding in surgery. Academic Article
-
Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis Academic Article
-
Pharmacology of the low-molecular-weight heparins Academic Article
-
Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications Academic Article
-
Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? Academic Article
-
Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin Academic Article
-
Postoperative Low-Molecular-Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators Academic Article
-
Preclinical differentiation of low molecular weight heparins. Academic Article
-
Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment Academic Article
-
Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery Academic Article
-
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE Academic Article
-
Preventing thrombophilia-related complications of pregnancy: an update Academic Article
-
Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Academic Article
-
Prevention and treatment of venous thromboembolism in the elderly patient. Academic Article
-
Prevention of Deep Vein Thrombosis after Elective Hip Surgery Academic Article
-
Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
-
Prevention of Venous Thromboembolism Among Hospitalized Medical Patients Academic Article
-
Prevention of Venous Thrombosis After Elective Hip Surgery Academic Article
-
Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents Academic Article
-
Prevention of venous thromboembolism after surgery: A review of enoxaparin Academic Article
-
Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study Academic Article
-
Prise en charge d’une surdose intentionnelle d’héparine de bas poids moléculaire Academic Article
-
Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins Academic Article
-
Prophylactic doses of enoxaparin and heparin inhibit prothrombin activation. Academic Article
-
Prophylactically Effective Doses of Enoxaparin and Heparin Inhibit Prothrombin Activation Academic Article
-
Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent Academic Article
-
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study Academic Article
-
Prophylaxis of Venous Thromboembolism in Stroke Patients Academic Article
-
Präoperative Bewertung des Blutungs- und Thromboseembolierisikos Academic Article
-
Pulmonary Embolism in Pregnancy Academic Article
-
Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism Academic Article
-
Randomized Trial of Warfarin Nomograms Academic Article
-
Randomized Trial of Warfarin Nomograms Academic Article
-
Randomized trial of warfarin nomograms. Academic Article
-
Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis Conference Paper
-
Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins Academic Article
-
Recommendations on biosimilar low-molecular-weight heparins Academic Article
-
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis Academic Article
-
Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial Academic Article
-
Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty Academic Article
-
Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia Academic Article
-
Reviparin in acute myocardial infarction. Academic Article
-
Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal Academic Article
-
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study Academic Article
-
Routine heparin for patients with cancer? One answer, more questions Academic Article
-
Routine home treatment of deep vein thrombosis Academic Article
-
Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure: A Meta-analysis of Randomized Trials Academic Article
-
Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study. Academic Article
-
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence Academic Article
-
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer Academic Article
-
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE Academic Article
-
Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation Academic Article
-
Significant association with location of central venous line placement and risk of venous thrombosis in children Academic Article
-
Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST) Academic Article
-
So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not? Academic Article
-
Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis Academic Article
-
State of the Art-A Journey through the World of Antithrombotic Therapy Academic Article
-
Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves Academic Article
-
Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST) Academic Article
-
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective Academic Article
-
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin Academic Article
-
Successors to heparin: new antithrombotic agents. Academic Article
-
Survey of pharmacologic thromboprophylaxis in critically ill children* Academic Article
-
Symptomatic venous thromboembolism after orthognathic operations: An audit Academic Article
-
The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate Academic Article
-
The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells Academic Article
-
The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty Academic Article
-
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism Academic Article
-
The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro Academic Article
-
The Efficacy and Safety of Heparin in Patients With Sepsis Academic Article
-
The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis Conference Paper
-
The Perioperative Management of Antithrombotic Therapy Academic Article
-
The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement Academic Article
-
The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome Academic Article
-
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients Academic Article
-
The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig Academic Article
-
The emerging role of low-molecular-weight heparin in cardiovascular medicine Academic Article
-
The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery Academic Article
-
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians Academic Article
-
The new heparins Academic Article
-
The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin. Academic Article
-
The risk and prevention of venous thromboembolism in the pregnant traveller Academic Article
-
The safety of antithrombotic therapy during pregnancy Academic Article
-
The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol Academic Article
-
The status of new anticoagulants Academic Article
-
The uses of heparin to treat burn injury. Academic Article
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 Academic Article
-
Therapy of unstable angina with the low molecular weight heparins Academic Article
-
Think of HIT When Thrombosis Follows Heparin Academic Article
-
Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis Academic Article
-
Thromboembolism in children with sarcoma Academic Article
-
Thromboembolism prevention in ischaemic stroke Academic Article
-
Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction Conference Paper
-
Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis Academic Article
-
Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ? Academic Article
-
Thromboprophylaxis after Knee Arthroscopy Academic Article
-
Thromboprophylaxis in Medical Patients – Why Not For All? Conference Paper
-
Thromboprophylaxis in Patients Receiving Chemotherapy Academic Article
-
Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin Academic Article
-
Thromboprophylaxis in medical–surgical critically ill patients Academic Article
-
Thromboprophylaxis in surgical patients. Academic Article
-
Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients Academic Article
-
Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit Academic Article
-
Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. Academic Article
-
Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial Academic Article
-
Thrombosis and cancer: implications beyond Trousseau Academic Article
-
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial Academic Article
-
To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections Academic Article
-
Treatment and prophylaxis of venous thromboembolism during pregnancy Academic Article
-
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
-
Treatment of Venous Thromboembolism in Cancer Patients Academic Article
-
Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management Academic Article
-
Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis Academic Article
-
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Academic Article
-
Unanswered questions in venous thromboembolism Academic Article
-
Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction Academic Article
-
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis Academic Article
-
Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis Academic Article
-
Unstable angina. Academic Article
-
Unstable angina. Academic Article
-
Updates in thrombosis in pediatrics: where are we after 20 years? Academic Article
-
Urologic Surgery Academic Article
-
Use of Antithrombotic Agents During Pregnancy Academic Article
-
Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes Academic Article
-
Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions Academic Article
-
Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children Academic Article
-
Use of antithrombotic agents during pregnancy. Academic Article
-
Using low molecular weight heparin in special patient populations Academic Article
-
VTE Prophylaxis in Critically Ill Adults Academic Article
-
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Academic Article
-
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 Academic Article
-
Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials Academic Article
-
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy Academic Article
-
Venous thromboembolism in critical illness in a community intensive care unit Academic Article
-
Venous thromboembolism in pregnancy: diagnosis, management and prevention Academic Article
-
Venous thromboembolism: diagnosis and management of deep venous thrombosis Academic Article
-
Venous thromboembolism: diagnosis and management of pulmonary embolism Academic Article
-
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism Academic Article
-
Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K Academic Article
-
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more Academic Article
-
What is the role for antithrombotics in cancer care? Academic Article
-
Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada? Academic Article
-
Women’s values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study Academic Article
-
Work-related effort thrombosis in a millwright: A case report Academic Article
-
[Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome]. Academic Article
-
[Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer]. Academic Article
-
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update]. Academic Article
-
“Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome Academic Article